… The clinical trials data indicate that inhaled corticosteroids … to inhaled corticosteroids
appears to increase clinical benefits … However, these benefits must be balanced against their …

… In this narrative review, we will focus on the scientific evidence supporting treatment with
inhaled corticosteroids (ICS) in COPD, including treatment with combinations of long acting β-…

… Benefits The benefits of inhaled corticosteroids were first … clinical trials. These trials were
originally designed to find out whether inhaled corticosteroids could replace oral corticosteroids. …

… inhaled corticosteroid with claimed improved risk/benefit ratio has been introduced into
clinical … and benefits of inhaled corticosteroids and to assess the claims for new preparations. …

… patients with asthma, inhaled corticosteroids have been assumed … with stable COPD received
inhaled corticosteroids,[5–7] … to evaluate the benefits and risks of inhaled corticosteroids in …

… The aim of this review is to evaluate the benefits and risks of inhaled corticosteroids, alone
and combined with inhaled long-acting β2-agonists, in COPD patients from the analysis of …

… In conclusion, sputum eosinophilia predicts short-term clinical benefit from high-dose
inhaled corticosteroid treatment in patients with stable moderate-to-severe chronic obstructive …

… asthma at lower doses of corticosteroids. By contrast, ICS provide much less clinical benefit
in COPD and the inflammation is resistant to the action of corticosteroids. This appears to be …

… benefits of inhaled corticosteroids (ICS) … benefits and risks of ICS in patients with COPD.
This article is based on a review of the literature (PubMed: COPD AND inhaled corticosteroids…

… suggests a modest benefit from inhaled corticosteroid long-… risk of pneumonia with the inhaled
corticosteroids currently available (… Inhaled corticosteroids have no cardiovascular effects. …